By Elias Schisgall
Emergent BioSolutions received Food and Drug Administration approval for its multipack configuration of Narcan, the opioid-overdose-reversal drug.
The company said Friday that the FDA greenlit over-the-counter sales of Narcan in packs of six and 24. It said the multipack offerings would meet the needs of community programs and organizations that distribute Narcan at a large scale.
"The introduction of Narcan Nasal Spray multipacks marks a significant step in empowering our partners on the front line," Paul Williams, Emergent's head of products business and global government and public affairs, said.
"They can now better streamline bulk distribution, support broad preparedness efforts, and ultimately ensure that more communities and individuals have ready access to this life-saving medication in the event of an opioid overdose emergency," he added.
Write to Elias Schisgall at elias.schisgall@wsj.com
(END) Dow Jones Newswires
02-12-26 1851ET
